Life sciences veteran executive Thomas Clement has joined

LipoScience, a provider of diagnostic technology based on nuclear magnetic resonance technology, as the firm’s vice president for regulatory and quality affairs.

“Tom has successfully registered a variety of diagnostic and biological products and brings with him a breadth of knowledge of the regulated industry,” said Richard O. Brajer, chief executive officer of LipoScience. “Today’s regulatory environment is becoming increasingly more complex with the development of new technologies and applications and Tom possesses the skills and experience needed to lead LipoScience and our products in the right direction.”

Clement has worked with the U.S. Food and Drug Administration. He most recently served as vice president of global regulatory and clinical affairs at Qiagen.

Get the latest news alerts: Follow WRAL Tech Wire at Twitter.